ArticleEmerging microbes & infections2022

Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis

Hongbo Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.